A comparison of prognostic systems in hepatocellular carcinoma treated with sorafenib.

被引：0
|
作者：
Bagnall, Elizabeth Marie
Gresham, Gillian
Czaykowski, Piotr
Chan, Kelvin K.
Fung, Jennifer
Cuvelier, Susan
Cheung, Winson Y.
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
[3] CancerCare Manitoba, Winnipeg, MB, Canada
[4] Univ Toronto, Sunnybrook Odette Canc Ctr, Toronto, ON, Canada
[5] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
[6] Univ Manitoba, Winnipeg, MB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e17696
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17696
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Prognostic impact of pERK in advanced hepatocellular carcinoma patients treated with sorafenib
    Chen, D.
    Zhao, P.
    Li, S. -Q.
    Xiao, W. -K.
    Yin, X. -Y.
    Peng, B. -G.
    Liang, L. -J.
    EJSO, 2013, 39 (09): : 974 - 980
  • [22] Prognostic significance of adverse events in patients with hepatocellular carcinoma treated with sorafenib
    Granito, Alessandro
    Marinelli, Sara
    Negrini, Giulia
    Menetti, Saverio
    Benevento, Francesca
    Bolondi, Luigi
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2016, 9 (02): : 240 - 249
  • [23] IGF-Child-Pugh score as a predictor of treatment outcome in advanced hepatocellular carcinoma patients treated with sorafenib.
    Abugabal, Yehia I.
    Hassan, Manal
    Pestana, Roberto
    Xiao, Lianchun
    Girard, Lauren
    Raghav, Kanwal Pratap Singh
    Morris, Jeffrey
    Abdel-Wahab, Reham
    Wolff, Robert A.
    Yao, James C.
    Amin, Hesham M.
    Kaseb, Ahmed Omar
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [24] Intermediate and advanced hepatocellular carcinoma treated with the antiangiogenic agent sorafenib. Evaluation with unenhanced and contrast-enhanced ultrasonography
    Moschouris, Hippocrates
    Malagari, Katerina
    Gkoutzios, Panagiotis
    Kalokairinou, Marianna
    Stamatiou, Konstantinos
    Chatzimichail, Katerina
    Kornezos, Ioannis
    Karagiannis, Evagelos
    Kiltenis, Michail
    Papadaki, Marina Georgiou
    MEDICAL ULTRASONOGRAPHY, 2012, 14 (02) : 87 - 94
  • [25] Comparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experience
    Endo, Masatsugu
    Nishikawa, Hiroki
    Kita, Ryuichi
    Kimura, Toru
    Ohara, Yoshiaki
    Sakamoto, Azusa
    Saito, Sumio
    Nishijima, Norihiro
    Nasu, Akihiro
    Komekado, Hideyuki
    Osaki, Yukio
    MOLECULAR AND CLINICAL ONCOLOGY, 2016, 4 (04) : 515 - 522
  • [26] Serum Glycan as a Prognostic Marker in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
    Miyahara, Koji
    Nouso, Kazuhiro
    Miyake, Yasuhiro
    Nakamura, Shinichiro
    Obi, Shuntaro
    Amano, Maho
    Hirose, Kazuko
    Nishimura, Shin-ichiro
    Yamamoto, Kazuhide
    HEPATOLOGY, 2014, 59 (01) : 355 - 356
  • [27] Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis
    Liu, Lixing
    Gong, Yang
    Zhang, Qinglin
    Cai, Panpan
    Feng, Li
    FRONTIERS IN ONCOLOGY, 2020, 9
  • [28] Prognostic roles of diabetes mellitus and hypertension in advanced hepatocellular carcinoma treated with sorafenib
    Hsieh, Ming-Han
    Kao, Tzu-Yu
    Hsieh, Ting-Hui
    Kao, Chun-Chi
    Peng, Cheng-Yuan
    Lai, Hsueh-Chou
    Chuang, Po-Heng
    Kao, Jung-Ta
    PLOS ONE, 2020, 15 (12):
  • [29] Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib
    Hiraoka, Atsushi
    Hirooka, Masashi
    Koizumi, Yohei
    Izumoto, Hirofumi
    Ueki, Hidetaro
    Kaneto, Miho
    Kitahata, Shogo
    Aibiki, Toshihiko
    Tomida, Hideomi
    Miyamoto, Yuji
    Yamago, Hiroka
    Suga, Yoshifumi
    Iwasaki, Ryuichiro
    Mori, Kenichiro
    Miyata, Hideki
    Tsubouchi, Eiji
    Kishida, Masato
    Ninomiya, Tomoyuki
    Abe, Masanori
    Matsuura, Bunzo
    Kawasaki, Hideki
    Hiasa, Yoichi
    Michitaka, Kojiro
    HEPATOLOGY RESEARCH, 2017, 47 (06) : 558 - 565
  • [30] Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib (vol 12, e00335, 2021)
    Sansone, Vito
    Tovoli, Francesco
    Casadei-Gardini, Andrea
    Di Costanzo, Giovan Giuseppe
    Magini, Giulia
    Sacco, Rodolfo
    Pressiani, Tiziana
    Trevisani, Franco
    Rimini, Margherita
    Tortora, Raffaella
    Nardi, Elena
    Ielasi, Luca
    Piscaglia, Fabio
    Granito, Alessandro
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2021, 12 (05)
12345